Trisalus Life Sciences Stock Today
| TLSI Stock | 5.29 0.19 3.73% |
PerformanceOK
| Odds Of DistressLow
|
TriSalus Life is trading at 5.29 as of the 21st of March 2025. This is a 3.73% up since the beginning of the trading day. The stock's open price was 5.1. TriSalus Life has less than a 16 % chance of experiencing some financial distress in the next two years of operation and had a ok performance during the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Moving against TriSalus Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
TriSalus Stock Highlights
| President CEO | MBA BSN |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
| Financial Strength | |
TriSalus Life Sciences (TLSI) is traded on NASDAQ Exchange in USA. It is located in 6272 West 91st Avenue, Westminster, CO, United States, 80031 and employs 116 people. TriSalus Life is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 161.31 M. TriSalus Life Sciences conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 30.49 M outstanding shares of which 127.98 K shares are at this time shorted by private and institutional investors with about 3.29 trading days to cover.
TriSalus Life generates negative cash flow from operations
Check TriSalus Life Probability Of Bankruptcy
Ownership AllocationTriSalus Life Sciences shows a total of 30.49 Million outstanding shares. TriSalus Life Sciences maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check TriSalus Ownership Details
TriSalus Life Sciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. TriSalus Life market risk premium is the additional return an investor will receive from holding TriSalus Life long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.124 | |||
| Jensen Alpha | 0.4842 | |||
| Total Risk Alpha | 0.8308 | |||
| Sortino Ratio | 0.1226 |
TriSalus Stock Against Markets
TriSalus Life Corporate Management
| Lori Santamaria | Vice Operations | Profile | |
| Rachel Garcia | Marketing Manager | Profile | |
| Bryan Cox | Chief Research | Profile | |
| James Young | Senior Treasurer | Profile | |
| Sean Murphy | Strategy Manufacturing | Profile | |
| MD FACS | Chief Board | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TriSalus Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.